RESUMEN
BACKGROUND: Few studies have investigated differences in the vulnerabilities of males and females to alcohol use disorder and alcohol-related brain damage (ARBD). According to epidemiological and clinical findings, females appear to be more sensitive to the effects of alcohol and thiamine deficiency and have a worse prognosis in recovery from neurocognitive deficits compared with males. This study aimed to characterize the effects of chronic ethanol (EtOH) toxicity and thiamine deficiency across the sexes using rodent models. METHODS: Male and female Sprague Dawley rats were assigned to chronic forced EtOH treatment (CET), pyrithiamine-induced thiamine deficiency (PTD), combined CET-PTD, or pair-fed (PF) control treatment conditions. Following treatments, spatial working memory was assessed during a spontaneous alternation task while measuring acetylcholine (ACh) in the prefrontal cortex (PFC) and the hippocampus (HPC). The animals also underwent an operant-based attentional set-shifting task (ASST) for the analysis of behavioral flexibility. RESULTS: Female and male rats did not differ in terms of EtOH consumption; however, the CET and CET-PTD-treated female rats had lower BECs than male rats. Compared with the PF group, the CET, PTD, and CET-PTD groups exhibited spatial working memory impairments with corresponding reductions in ACh efflux in the PFC and HPC. The ASST revealed that CET-PTD-treated males and females displayed impairments marked by increased latency to make decisions. Thalamic shrinkage was prominent only in the CET-PTD and PTD treatment conditions, but no sex-specific effects were observed. CONCLUSIONS: Although the CET and CET-PTD-treated females had lower BECs than the males, they demonstrated similar cognitive impairments. These results provide evidence that female rats experience behavioral and neurochemical disruptions at lower levels of alcohol exposure than males and that chronic EtOH and thiamine deficiencies produce a unique behavioral profile.
Asunto(s)
Acetilcolina/metabolismo , Alcoholismo/metabolismo , Depresores del Sistema Nervioso Central/farmacología , Etanol/farmacología , Hipocampo/efectos de los fármacos , Corteza Prefrontal/efectos de los fármacos , Deficiencia de Tiamina/metabolismo , Alcoholismo/complicaciones , Alcoholismo/fisiopatología , Animales , Antimetabolitos/toxicidad , Atención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Estudios de Casos y Controles , Femenino , Hipocampo/metabolismo , Masculino , Microdiálisis , Corteza Prefrontal/metabolismo , Piritiamina/toxicidad , Ratas , Factores Sexuales , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/fisiopatologíaRESUMEN
Thiamine deficiency (TD), commonly associated with chronic alcoholism, leads to diencephalic damage, hippocampal dysfunction, and spatial learning and memory deficits. We show a decrease in the magnitude of long-term potentiation (LTP) and paired-pulse facilitation (PPF) at CA3-CA1 synapses, independent of sex, following diencephalic damage induced by TD in rats. Thus, despite a lack of extensive hippocampal cell loss, diencephalic brain damage down-regulates plastic processes within the hippocampus, likely contributing to impaired hippocampal-dependent behaviors. However, both measures of hippocampal plasticity (LTP, PPF) were restored with brain-derived neurotrophic factor (BDNF), revealing an avenue for neural and behavioral recovery following diencephalic damage.
Asunto(s)
Lesiones Encefálicas/etiología , Factor Neurotrófico Derivado del Encéfalo/uso terapéutico , Diencéfalo/patología , Hipocampo , Potenciación a Largo Plazo/efectos de los fármacos , Deficiencia de Tiamina/complicaciones , Animales , Antimetabolitos/toxicidad , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Modelos Animales de Enfermedad , Estimulación Eléctrica , Femenino , Hipocampo/metabolismo , Hipocampo/patología , Hipocampo/fisiopatología , Potenciación a Largo Plazo/fisiología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Piritiamina/toxicidad , Ratas , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/patologíaRESUMEN
Prolonged vitamin B1 (thiamine) deficiency can lead to neurological disorders such as Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome (WKS) in humans. These thiamine deficiency disorders have been attributed to vascular leakage, blood-brain barrier breakdown and neuronal loss in the diencephalon and brain stem. However, endothelial dysfunction following thiamine deficiency and its relationship to the phenomenon of neurodegeneration has not been clearly elucidated. The present study sought to begin to address this issue by evaluating vascular morphology and integrity in a pyrithiamine (PT)-induced rat model of thiamine deficiency. Adjacent brain sections were used to either assess vascular integrity through immunohistochemical localization of rat endothelial cell antigen (RECA-1) and endothelial brain barrier antigen (EBA-1) or neurodegeneration using the de Olmos cupric silver method. GFAP and CD11b immunolabeling was used to evaluate astrocytic and microglial/macrophagic changes. Extensive neurodegeneration occurred concomitant with both vascular damage (thinning and breakage) and microglial activation in the inferior olive, medial thalamic area, and medial geniculate nuclei of pyrithiamine treated rats. Likewise, glucose transporter-1 (Glut-1), which is mostly expressed in endothelial cells, was also severely decreased in this pyrithiamine induced thiamine deficient rat model. MRI scans of these animals prior to sacrifice show that the pyrithiamine induced thiamine deficient animals have abnormal T2 relaxation values, which are commensurate with, and possibly predictive of, the neurodegeneration and/or endothelial dysfunction subsequently observed histologically in these same animals.
Asunto(s)
Antimetabolitos/toxicidad , Encéfalo/patología , Células Endoteliales/efectos de los fármacos , Piritiamina/toxicidad , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/patología , Animales , Antígenos de Superficie/metabolismo , Astrocitos/patología , Astrocitos/ultraestructura , Encéfalo/diagnóstico por imagen , Antígeno CD11b/metabolismo , Modelos Animales de Enfermedad , Células Endoteliales/ultraestructura , Proteína Ácida Fibrilar de la Glía/metabolismo , Proteínas Facilitadoras del Transporte de la Glucosa/metabolismo , Transportador de Glucosa de Tipo 1/metabolismo , Imagen por Resonancia Magnética , Masculino , Enfermedades Neurodegenerativas/diagnóstico por imagen , Enfermedades Neurodegenerativas/etiología , Ratas , Ratas Sprague-Dawley , Tinción con Nitrato de Plata , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/diagnóstico por imagenRESUMEN
Exercise has been shown to improve cognitive functioning in a range of species, presumably through an increase in neurotrophins throughout the brain, but in particular the hippocampus. The current study assessed the ability of exercise to restore septohippocampal cholinergic functioning in the pyrithiamine-induced thiamine deficiency (PTD) rat model of the amnestic disorder Korsakoff Syndrome. After voluntary wheel running or sedentary control conditions (stationary wheel attached to the home cage), PTD and control rats were behaviorally tested with concurrent in vivo microdialysis, at one of two time points: 24-h or 2-weeks post-exercise. It was found that only after the 2-week adaption period did exercise lead to an interrelated sequence of events in PTD rats that included: (1) restored spatial working memory; (2) rescued behaviorally-stimulated hippocampal acetylcholine efflux; and (3) within the medial septum/diagonal band, the re-emergence of the cholinergic (choline acetyltransferase [ChAT+]) phenotype, with the greatest change occurring in the ChAT+/nestin+ neurons. Furthermore, in control rats, exercise followed by a 2-week adaption period improved hippocampal acetylcholine efflux and increased the number of neurons co-expressing the ChAT and nestin phenotype. These findings demonstrate a novel mechanism by which exercise can modulate the mature cholinergic/nestin neuronal phenotype leading to improved neurotransmitter function as well as enhanced learning and memory.
Asunto(s)
Acetilcolina/metabolismo , Hipocampo/metabolismo , Nestina/metabolismo , Neuronas/fisiología , Tabique del Cerebro/patología , Conducta Espacial/fisiología , Deficiencia de Tiamina/rehabilitación , Animales , Antimetabolitos/toxicidad , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Colina O-Acetiltransferasa/metabolismo , Modelos Animales de Enfermedad , Terapia por Ejercicio , Masculino , Actividad Motora/efectos de los fármacos , Factor de Crecimiento Nervioso/metabolismo , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Reconocimiento en Psicología/fisiología , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/patología , Deficiencia de Tiamina/fisiopatología , Factores de TiempoRESUMEN
Thiamine deficiency (TD) is the underlying cause of Wernicke's encephalopathy (WE), an acute neurological disorder characterized by structural damage to key periventricular structures in the brain. Increasing evidence suggests these focal histological lesions may be representative of a gliopathy in which astrocyte-related changes are a major feature of the disorder. These changes include a loss of the glutamate transporters GLT-1 and GLAST concomitant with elevated interstitial glutamate levels, lowered brain pH associated with increased lactate production, decreased levels of GFAP, reduction in the levels of glutamine synthetase, swelling, alterations in levels of aquaporin-4, and disruption of the blood-brain barrier. This review focusses on how these manifestations contribute to the pathophysiology of TD and possibly WE.
Asunto(s)
Astrocitos/fisiología , Deficiencia de Tiamina/fisiopatología , Sistema de Transporte de Aminoácidos X-AG/fisiología , Animales , Transporte Biológico , Barrera Hematoencefálica , Encéfalo/patología , Modelos Animales de Enfermedad , Transportador 2 de Aminoácidos Excitadores/fisiología , Ácido Glutámico/metabolismo , Humanos , Complejo Cetoglutarato Deshidrogenasa/fisiología , Proteínas del Tejido Nervioso/fisiología , Neuronas/metabolismo , Neuronas/patología , Estrés Oxidativo , Piritiamina/toxicidad , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/metabolismo , Encefalopatía de Wernicke/etiología , Encefalopatía de Wernicke/metabolismo , Encefalopatía de Wernicke/fisiopatologíaRESUMEN
Thiamine deficiency (TD) leads to Wernicke's encephalopathy (WE), in which focal histological lesions occur in periventricular areas of the brain. Recently, impaired neurogenesis has been reported in the hippocampus during the dietary form of TD, and in pyrithiamine-induced TD (PTD), a well-characterized model of WE. To further characterize the consequences of PTD on neural stem/progenitor cell (NSPC) activity, we have examined the effect of this treatment in the rat on both the subventricular zone (SVZ) of the rostral lateral ventricle and subgranular layer (SGL) of the hippocampus, and in the thalamus and inferior colliculus, two vulnerable brain regions in this disorder. In both the SVZ and SGL, PTD led to a decrease in the numbers of bromodeoxyuridine-stained cells, indicating that proliferation of NSPCs destined for neurogenesis in these areas was reduced. Doublecortin (DCX) immunostaining in the SGL was decreased, indicating a reduction in neuroblast formation, consistent with impaired NSPC activity. DCX labeling was not apparent in focal areas of vulnerability. In the thalamus, proliferation of cells was absent while in the inferior colliculus, numerous actively dividing cells were apparent, indicative of a differential response between these two brain regions. Exposure of cultured neurospheres to PTD resulted in decreased proliferation of NSPCs, consistent with our in vivo findings. Together, these results indicate that PTD considerably affects cell proliferation and neurogenesis activity in both neurogenic areas and parts of the brain known to display structural and functional vulnerability, confirming and extending recent findings on the effects of TD on neurogenesis. Future use of NSPCs in vitro may allow a closer and more detailed examination of the mechanism(s) underlying inhibition of these cells during TD.
Asunto(s)
Encéfalo/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Piritiamina/toxicidad , Encefalopatía de Wernicke/patología , Animales , Encéfalo/patología , División Celular/efectos de los fármacos , Células Cultivadas , Replicación del ADN/efectos de los fármacos , Modelos Animales de Enfermedad , Proteínas de Dominio Doblecortina , Proteína Doblecortina , Hipocampo/efectos de los fármacos , Hipocampo/patología , Colículos Inferiores/efectos de los fármacos , Colículos Inferiores/patología , Ventrículos Laterales/efectos de los fármacos , Ventrículos Laterales/patología , Masculino , Proteínas Asociadas a Microtúbulos/análisis , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/patología , Neuropéptidos/análisis , Ratas , Ratas Sprague-Dawley , Tálamo/efectos de los fármacos , Tálamo/patología , Encefalopatía de Wernicke/inducido químicamenteRESUMEN
Thiamine (vitamin B1) deficiency (TD) leads to focal brain necrosis in particular brain regions in humans and in experimental animal models. The precise mechanism of the selective topographic vulnerability triggered by TD still remains unclear. We examined the distribution pattern of cell death in the brains of mice in an experimental model of TD using anti-single-strand DNA immunohistochemistry and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling methods. We found that interneurons in the olfactory bulb were sensitive to TD. The morphologic aspects of cell death in the olfactory bulb resembled those of cell death in thalamic neurons, which have previously been examined in detail. Furthermore, cell death in the olfactory bulb was partly relieved by the administration of an N-methyl-d-aspartate receptor antagonist, as was the case in thalamic lesions by TD. The superficial part of the olfactory granule cell layer seemed to be the most sensitive to TD, suggesting that differences in the afferents between superficial and deep granule cells may influence the sensitivity of these cells to TD. Our results indicate that the olfactory bulb should be considered as one of the vulnerable regions to TD.
Asunto(s)
Neuronas/patología , Bulbo Olfatorio/patología , Deficiencia de Tiamina/patología , Animales , Antimetabolitos/toxicidad , Proteínas de Unión al Calcio/metabolismo , Caspasa 3/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , ADN de Cadena Simple/metabolismo , Modelos Animales de Enfermedad , Etiquetado Corte-Fin in Situ , Masculino , Ratones , Ratones Endogámicos DBA , Proteínas de Microfilamentos/metabolismo , Microglía/patología , Microglía/ultraestructura , N-Metilaspartato/farmacología , Neuronas/metabolismo , Bulbo Olfatorio/ultraestructura , Piritiamina/toxicidad , Tiamina/metabolismo , Deficiencia de Tiamina/etiologíaRESUMEN
Decreased thiamine-dependent enzyme activity and/or thiamine deficiency (TD) have been linked to Alzheimer's disease (AD). In this study, we administered pyrithiamine, an anti-thiamine compound, to both APP/PS1 transgenic mice and wild-type littermate control mice; alternatively, we induced TD by thiamine-depleted diet. Pyrithiamine treatment and diet-induced TD impaired the memory of wild-type mice, but had little effect on APP/PS1 mice. Pathophysiologically, pyrithiamine treatment and diet-induced TD aggravated ß-amyloid accumulation in the brain. This was demonstrated by increased ß-amyloid in the brains of wild-type mice using ELISA and by the number of amyloid plaques in the brains of APP/PS1 transgenic mice using immunochemical staining. Also, enhanced numbers of phosphorylated Tau-positive cells were observed in both APP/PS1 transgenic and wild-type mice. Furthermore, pyrithiamine decreased the phosphorylation rates of glycogen synthase kinase (GSK)-3ß and raised its enzymatic activity, but had little influence on GSK-3α. Diet-induced TD reduced the phosphorylated rates and increased the activities of GSK-3, GSK-3α, and GSK-3ß. These results suggest that when sufficient thiamine supplement is administered, pyrithiamine can cause AD-like pathological alterations similar to that of diet-induced TD.
Asunto(s)
Péptidos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Glucógeno Sintasa Quinasa 3/metabolismo , Piritiamina/toxicidad , Proteínas tau/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Glucógeno Sintasa Quinasa 3 beta , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Transgénicos , Fosforilación/efectos de los fármacos , Fosforilación/fisiología , Distribución AleatoriaRESUMEN
Wernicke's encephalopathy is a cerebral disorder caused by thiamine (vitamin B(1)) deficiency (TD). Neuropathologic consequences of TD include region-selective neuronal cell loss and blood-brain barrier (BBB) breakdown. Early increased expression of the endothelial isoform of nitric oxide synthase (eNOS) occurs selectively in vulnerable brain regions in TD. We hypothesize that region-selective eNOS induction in TD leads to altered expression of tight junction proteins and BBB breakdown. In order to address this issue, TD was induced in C57BL/6 wild-type (WT) and eNOS(-/-) mice by feeding a thiamine-deficient diet and treatment with the thiamine antagonist pyrithiamine. Pair-fed control mice were fed the same diet with additional thiamine. In medial thalamus of TD-WT mice (vulnerable area), increased heme oxygenase-1 and S-nitrosocysteine immunostaining was observed in vessel walls, compared to pair-fed control-WT mice. Concomitant increases in IgG extravasation, decreases in expression of the tight junction proteins occludin, zona occludens-1 and zona occludens-2, and up-regulation of matrix metalloproteinase-9 in endothelial cells were observed in the medial thalamus of TD-WT mice. eNOS gene deletion restored these BBB alterations, suggesting that eNOS-derived nitric oxide is a major factor leading to cerebrovascular alterations in TD. However, eNOS gene deletion only partially attenuated TD-related neuronal cell loss, suggesting the presence of mechanisms additional to BBB disruption in the pathogenesis of these changes.
Asunto(s)
Barrera Hematoencefálica/fisiología , Degeneración Nerviosa/fisiopatología , Óxido Nítrico Sintasa de Tipo III/genética , Óxido Nítrico Sintasa de Tipo III/metabolismo , Núcleos Talámicos/fisiología , Deficiencia de Tiamina/fisiopatología , Animales , Antimetabolitos/toxicidad , Modelos Animales de Enfermedad , Lóbulo Frontal/patología , Lóbulo Frontal/fisiología , Inmunoglobulina G/metabolismo , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/metabolismo , Estrés Oxidativo/fisiología , Piritiamina/toxicidad , Especies de Nitrógeno Reactivo/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Núcleos Talámicos/patología , Deficiencia de Tiamina/metabolismoRESUMEN
Wernicke's encephalopathy (WE) is characterized by lesions in thalamus, hypothalamus (including mammillary nuclei), and inferior colliculi, results in serious disabilities, has an etiology of thiamine deficiency, is treatable with thiamine, and occurs most commonly with alcoholism. Despite decades of study, whether alcohol exposure exacerbates the neuropathology or retards its resolution remains controversial. To examine patterns of brain damage and recovery resulting from thiamine deprivation with and without alcohol exposure, we conducted in vivo magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) at 3 T in alcohol-preferring (P) rats, which had voluntarily consumed large amounts of alcohol before thiamine manipulation. A total of 18 adult male P rats (nine alcohol-exposed) received a thiamine-deficient diet for 2 weeks: 10 (five alcohol-exposed) received intraperitoneal (i.p.) pyrithiamine (PT) and eight (four alcohol-exposed) received i.p. thiamine supplementation. Neurological signs developed by day 14. Rats were scanned before thiamine depletion and 18 and 35 days after thiamine repletion. Two-dimensional J-resolved MRS single-voxel spectra with water reference were collected in a voxel subtending the thalamus; metabolite quantification was corrected for voxel tissue content. MRI identified significant enlargement of dorsal ventricles and increase in signal intensities in thalamus, inferior colliculi, and mammillary nuclei of PT compared with thiamine-treated (TT) groups from MRI 1-2, followed by significant normalization from MRI 2-3 in thalamus and colliculi, but not mammillary nuclei and lateral ventricles. Voxel-by-voxel analysis revealed additional hyperintense signal clusters in the dorsal and ventral hippocampus and enlargement of the fourth ventricle. MRS showed a significant decline and then partial recovery in thalamic N-acetylaspartate, a marker of neuronal integrity, in PT compared with TT rats, with no change detected in creatine, choline, or glutamate. PT rats with prior alcohol exposure exhibited attenuated recovery in the thalamus and arrested growth of the corpus callosum; further, two of the five alcohol-exposed PT rats died prematurely. Parenchymal and ventricular changes with thiamine manipulation concur with human radiological signs of WE. The enduring macrostructural and neurochemical abnormalities involving critical nodes of Papez circuit carry liabilities for development of amnesia and incomplete recovery from other cognitive and motor functions subserved by the affected neural systems.
Asunto(s)
Trastornos del Sistema Nervioso Inducidos por Alcohol/metabolismo , Encéfalo/efectos de los fármacos , Etanol/toxicidad , Degeneración Nerviosa/inducido químicamente , Piritiamina/toxicidad , Deficiencia de Tiamina/metabolismo , Trastornos del Sistema Nervioso Inducidos por Alcohol/patología , Trastornos del Sistema Nervioso Inducidos por Alcohol/fisiopatología , Alcoholismo/metabolismo , Alcoholismo/fisiopatología , Animales , Antimetabolitos/toxicidad , Biomarcadores/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Depresores del Sistema Nervioso Central/toxicidad , Modelos Animales de Enfermedad , Síndrome de Korsakoff/inducido químicamente , Síndrome de Korsakoff/patología , Síndrome de Korsakoff/fisiopatología , Estudios Longitudinales , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Masculino , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/fisiopatología , Ratas , Ratas Wistar , Tasa de Supervivencia , Tiamina/antagonistas & inhibidores , Tiamina/metabolismo , Deficiencia de Tiamina/fisiopatologíaRESUMEN
Metabolic dysfunction as a consequence of thiamine (vitamin B1) deficiency (TD), a model of Wernicke's encephalopathy, leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity. Complexin I and complexin II are two genes labeling principally inhibitory and excitatory synapses, respectively. Because current evidence supports an important role for complexins in the modulation of neurotransmitter release, we examined the involvement of both proteins in the pathology of the medial thalamus and inferior colliculus in TD rats by immunoblotting. At the symptomatic stage, complexin I and complexin II levels in the medial thalamus were decreased by 63% and 45%, respectively, compared to control animals, but were unchanged in the inferior colliculus. These changes in thalamus were also observed using immunohistochemical methods, and seemed to be due to downregulation of both proteins because synaptophysin levels were unaffected in this brain region. In addition, cotreatment with the antioxidant N- acetylcysteine prevented both neuronal loss and downregulation of complexins. Our findings suggest dysregulation of excitatory and inhibitory neurotransmitter release in the medial thalamus, which is not present in the inferior colliculus. Furthermore, loss of complexin I and II in the thalamus may be mediated by processes that involve oxidative stress. Such changes in complexin levels may contribute to the pathophysiology of thalamic damage in TD, and offer a potential basis for the well-known differences in pathology between this structure and the inferior colliculus in this disorder.
Asunto(s)
Acetilcisteína/farmacología , Proteínas del Tejido Nervioso/metabolismo , Tálamo/efectos de los fármacos , Encefalopatía de Wernicke/metabolismo , Proteínas Adaptadoras del Transporte Vesicular , Animales , Antimetabolitos/metabolismo , Western Blotting/métodos , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Interacciones Farmacológicas , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica/métodos , Masculino , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Tálamo/metabolismo , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/metabolismo , Deficiencia de Tiamina/fisiopatología , Encefalopatía de Wernicke/inducido químicamente , Encefalopatía de Wernicke/fisiopatologíaRESUMEN
Imaging studies indicate that cerebral edema is an important consequence of Wernicke's encephalopathy (WE), a disorder caused by thiamine deficiency (TD). We have investigated this problem using a recently developed in vitro astrocyte model of TD. Measurement of cell volume using the 3-O-methylglucose uptake method revealed a dose-dependent swelling of astrocytes during exposure to TD conditions. Time course studies indicated a progressive volume increase up to a maximum of 93% above controls after 4 days of treatment. This swelling then partially resolved, and remained stable for up to 10 days following commencement of TD treatment. Measurement of aquaporin-4 (AQP-4) levels showed a 44% loss after 10 days and a temporal profile consistent with an important role for this water channel protein in astrocyte cell volume changes during TD. Our findings of astrocyte swelling in TD are consistent with previous reports of focal brain edema in cases of WE, and indicate that AQP-4 may be an important target for ameliorating some of the clinical problems associated with this disorder.
Asunto(s)
Acuaporinas/metabolismo , Astrocitos/fisiología , Corteza Cerebral/citología , Edema/metabolismo , Deficiencia de Tiamina/patología , 3-O-Metilglucosa , Animales , Animales Recién Nacidos , Acuaporina 4 , Astrocitos/efectos de los fármacos , Western Blotting/métodos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo/fisiología , Edema/etiología , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Tiamina/antagonistas & inhibidores , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/metabolismo , Factores de TiempoRESUMEN
Age is a risk factor for the development of many neurological disorders, including alcohol-related neurological disorders. A rodent model of Wernicke-Korsakoff Syndrome (WKS), acute pyrithiamine-induced thiamine deficiency (PTD), produces diencephalic damage and impairments of memory similar to what is seen in WKS patients. Advanced age increases the vulnerability to the cascade of acute and some chronic neurological events caused by PTD treatment. Interactions between PTD treatment and age at the time of treatment (3, 10, or 21 months), in addition to the effects of an increased recovery period, were examined relative to spatial memory impairment and neuropathology in Fischer 344 rats. Although acute neurological disturbances and medial thalamic brain lesions were more prevalent in middle-aged and senescent rats exposed to PTD treatment, relative to young rats, behavioral data did not support the view that PTD and aging have synergistic effects. In addition, both advanced age and PTD treatment result in a loss of basal forebrain cholinergic neurons, though there was no interaction. Despite the fact that no convincing evidence was found for an effect of extended recovery time on neuropathology measures, young rats given an extensive recovery period displayed less working memory impairment. In summary, these data provide evidence for an increased susceptibility of the aged rat to the acute neurological consequences and diencephalic pathology associated with PTD treatment and indicated a similar vulnerability of the middle-aged rat. However, the synergistic interaction between aging and PTD treatment in thalamic tissue loss did not express behaviorally.
Asunto(s)
Envejecimiento , Amnesia/etiología , Dieta , Síndrome de Korsakoff/fisiopatología , Deficiencia de Tiamina/fisiopatología , Tiamina/metabolismo , Envejecimiento/efectos de los fármacos , Envejecimiento/fisiología , Animales , Antimetabolitos/toxicidad , Conducta Animal , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Mapeo Encefálico , Recuento de Células , Ventrículos Cerebrales/patología , Colina O-Acetiltransferasa/metabolismo , Aprendizaje Discriminativo , Modelos Animales de Enfermedad , Inmunohistoquímica/métodos , Síndrome de Korsakoff/inducido químicamente , Masculino , Aprendizaje por Laberinto , Memoria a Corto Plazo/efectos de los fármacos , Memoria a Corto Plazo/fisiología , Prosencéfalo/efectos de los fármacos , Prosencéfalo/metabolismo , Prosencéfalo/patología , Piritiamina/toxicidad , Ratas , Ratas Endogámicas F344 , Conducta Espacial , Deficiencia de Tiamina/patología , Factores de TiempoRESUMEN
Experimental thiamine deficiency results in a reproducible pattern of selective neuronal cell death. Events such as blood-brain barrier breakdown, N-methyl-D-aspartic acid (NMDA) receptor-mediated excitotoxicity, and increased reactive oxygen species have been implicated in thiamine deficiency-induced neural loss. L-deprenyl protects dopaminergic, noradrenergic, and acetylcholinergic neurons from neurotoxic, mechanical, and excitotoxic damage. In the present study, the effects of l-deprenyl on neuronal cell survival were examined in rats made thiamine deficient by daily administration of the central thiamine antagonist pyrithiamine (0.5 mg/kg s.c.). Rats assigned to thiamine deficient or control groups received daily injections of l-deprenyl (0.25, 0.5, or 1.0 mg/kg/day i.p.) or vehicle until they reached a state of severe thiamine deficiency (loss of righting reflex). At this stage, thiamine status was restored by daily injections of thiamine (10 mg/kg s.c.) for 3 days, after which the animals were killed, and their brains were processed for neuronal cell counts (cresyl violet staining), astrocytic proliferation [glial fibrillary acidic protein (GFAP) immunohistochemistry], and monoamine oxidase B (MAO-B) activity. All rats receiving l-deprenyl (all doses) had significantly decreased neuronal cell loss in thalamic nuclei, in the inferior colliculus, and in the inferior olive and had a concomitant decrease in reactive astrocytic proliferation compared with the thiamine-deficient, vehicle-treated rats. The neuroprotective effects of l-deprenyl in thiamine deficiency induced brain damage most likely result from its properties other than its effects as an MAO-B inhibitor.
Asunto(s)
Inhibidores de la Monoaminooxidasa/uso terapéutico , Neuronas/efectos de los fármacos , Neuronas/patología , Selegilina/uso terapéutico , Deficiencia de Tiamina/tratamiento farmacológico , Deficiencia de Tiamina/patología , Animales , Conducta Animal/efectos de los fármacos , Recuento de Células/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Esquema de Medicación , Inmunohistoquímica , Inyecciones Intraperitoneales , Masculino , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Deficiencia de Tiamina/inducido químicamenteRESUMEN
Three experiments were conducted to examine the role of histamine in neuronal degeneration in a rat model of Wernicke's encephalopathy induced by an acute bout of pyrithiamine-induced thiamine deficiency (PTD). In the first experiment, histamine levels in medial thalamus of freely moving PTD rats measured by microdialysis were increased (180% of controls) at a prelesion stage of thiamine deficiency (treatment day 12) and further elevated 48 hr later (380%) in the same animals when necrosis was evident. Histamine levels in dialysates of the hippocampus collected simultaneously from the same animals were unchanged at either stage of thiamine deficiency. Glutamate levels in microdialysates from the same animals were unchanged at the prelesion stage but were significantly elevated on the second collection day. In a second experiment, separate groups of PTD and pairfed control (CT) rats were infused continuously with either alpha-fluoromethylhistidine (FMH; 80 mg/day, i.p.), an irreversible inhibitor of histamine synthesis, or saline. FMH pretreatment produced a significant protection against PTD-induced neuronal loss within the midline-intralaminar and anteromedial thalamic nuclei, but had no effect on damage to ventrolateral nuclei, anteroventral nucleus, or the mammillary bodies. In a third study, histamine (80 micrograms, free base) or vehicle was directly infused into the same region of medial thalamus dialyzed in experiment 1. Histamine infusion into prelesion PTD but not CT animals resulted in severe neuronal loss and gliosis. Infusion of vehicle into the same regions of PTD and CT rats produced a mild gliosis restricted to the needle tract with no evidence of neuronal loss. These observations together with recent evidence of a histamine enhancement of glutamate receptor activation suggest that early histamine release may contribute significantly to glutamate-N-methyl-D-aspartate (NMDA)-mediated excitotoxic neuronal death in thiamine deficiency-induced Wernicke's encephalopathy.
Asunto(s)
Modelos Animales de Enfermedad , Histamina/toxicidad , Degeneración Nerviosa/efectos de los fármacos , Tálamo/patología , Encefalopatía de Wernicke/patología , Animales , Muerte Celular , Gliosis/inducido químicamente , Gliosis/patología , Ácido Glutámico/análisis , Glutamina/metabolismo , Hipocampo/química , Hipocampo/efectos de los fármacos , Hipocampo/patología , Histamina/fisiología , Liberación de Histamina , Masculino , Metilhistidinas/farmacología , Microdiálisis , Necrosis , Neuroglía/metabolismo , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Receptores de Glutamato/efectos de los fármacos , Receptores de Glutamato/fisiología , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/fisiología , Tálamo/química , Tálamo/efectos de los fármacos , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/metabolismo , Encefalopatía de Wernicke/etiologíaRESUMEN
Treatment of rats with the central thiamine antagonist, pyrithiamine, results in severe neurological symptoms such as ataxia and convulsions. Induction of proto-oncogene c-fos expression, often related to seizure activity, has been detected in the brains of thiamine-deficient rats by means of Northern blot analysis and in situ hybridization. Region-selective increases of lactate observed following thiamine deficiency development are largely coincident with histologically vulnerable regions. When thiamine-deficient rats were treated with the calcium channel blocker, nicardipine, lesions associated with thiamine deficiency did not appear and there was no induction of c-fos mRNA expression. This suggests a neurocytoprotective role of nicardipine to neuronal cell damage in thiamine-deficient encephalopathy.
Asunto(s)
Expresión Génica/fisiología , Genes fos/fisiología , Nicardipino/uso terapéutico , Piritiamina/antagonistas & inhibidores , Encefalopatía de Wernicke/patología , Animales , Femenino , Hibridación in Situ , Lactatos/metabolismo , Sondas de Oligonucleótidos , Piritiamina/toxicidad , Ratas , Ratas Sprague-Dawley , Encefalopatía de Wernicke/inducido químicamente , Encefalopatía de Wernicke/metabolismoRESUMEN
In vivo, volume-selected 1H NMR spectroscopy employing the SPACE technique was used to monitor biochemical changes in the thiamin deficient rat brain in response to glucose loading. The concentrations of brain N-acetylaspartate, glutamate/glutamine/gamma-aminobutyric acid, lactate and glucose differed significantly from those of control animals. The results are consistent with a metabolic block at the reaction catalyzed by the thiamin dependent enzyme alpha-keto glutarate dehydrogenase soon after the onset of neurological symptoms of thiamin deficiency, and a further block at pyruvate dehydrogenase arising late in the course of thiamin deficiency.
Asunto(s)
Química Encefálica , Glucosa/farmacología , Espectroscopía de Resonancia Magnética , Deficiencia de Tiamina/metabolismo , Acidosis Láctica/etiología , Animales , Ácido Aspártico/análogos & derivados , Ácido Aspártico/análisis , Ataxia/etiología , Femenino , Glucosa/análisis , Glucosa/toxicidad , Glutamatos/análisis , Ácido Glutámico , Glutamina/análisis , Complejo Cetoglutarato Deshidrogenasa/metabolismo , Lactatos/análisis , Ácido Láctico , Piritiamina/toxicidad , Complejo Piruvato Deshidrogenasa/metabolismo , Ratas , Ratas Wistar , Deficiencia de Tiamina/complicaciones , Ácido gamma-Aminobutírico/análisisRESUMEN
Rats were trained on a spatial delayed-nonmatching-to-sample (DNMTS) task and assigned by block randomization to one of four treatments: pyrithiamine-induced thiamine deficiency (PTD), PTD with administration of MK-801 after 12 days, control with MK-801 treatment, and control without MK-801. After 15 days of treatment followed by 21 days of recovery, the PTD rats showed significant deficits for DNMTS accuracy at retention intervals (RI) that ranged from 3.0 s to 15.0 s, the RIs that produced 75% accuracy on DNMTS in staircase training, and the rate at which a novel radial arm maze task was learned. The PTD-treated rats had consistent lesions in the thalamus and the mammillary bodies. MK-801 protected rats from both behavioral deficits and brain lesions (assessed quantitatively and qualitatively) that were produced by the PTD treatment.
Asunto(s)
Trastorno Amnésico Alcohólico/fisiopatología , Aprendizaje Discriminativo/efectos de los fármacos , Maleato de Dizocilpina/farmacología , Recuerdo Mental/efectos de los fármacos , Orientación/efectos de los fármacos , Piritiamina/toxicidad , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Deficiencia de Tiamina/inducido químicamente , Encefalopatía de Wernicke/inducido químicamente , Animales , Conducta Apetitiva/efectos de los fármacos , Conducta Apetitiva/fisiología , Mapeo Encefálico , Aprendizaje Discriminativo/fisiología , Masculino , Recuerdo Mental/fisiología , Orientación/fisiología , Piritiamina/antagonistas & inhibidores , Ratas , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Receptores de N-Metil-D-Aspartato/fisiología , Retención en Psicología/efectos de los fármacos , Retención en Psicología/fisiología , Tálamo/efectos de los fármacos , Tálamo/fisiopatología , Deficiencia de Tiamina/fisiopatología , Encefalopatía de Wernicke/fisiopatologíaRESUMEN
The purpose of the present study was to design a standard battery of tests capable of quantitatively characterizing ataxia and concomitant neurological signs in the rat. In addition to a systematic analysis of the walking gait of animals, tests for activity, catalepsy, rigidity and various reflexive responses were included in the battery. The standardization of the test system was performed by determining and comparing neurobehavioral effects produced by 3-acetyl pyridine, acrylamide, pyrithiamine and thiamine deficiency, four experimental treatments reported to induce ataxia in animals. Results indicate that profiles of neurobehavioral disturbances accompanying ataxia in animals varied distinctively with each experimental treatment.